The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Arthritis Drug-Global Market Insights and Sales Trends 2024
Synopsis
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
The global Arthritis Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Arthritis Drug in various end use industries. The expanding demands from the Retail Pharmacies, Hospital Pharmacies, Drug Stores and E-Commerce, are propelling Arthritis Drug market. Synthetic DMARDs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological DMARDs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Arthritis Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Arthritis Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Arthritis Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Arthritis Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Arthritis Drug covered in this report include Novartis, Eli Lilly, Celltrion, F. Hoffmann-La Roche, Pfizer, Johnson & Johnson and GSK, etc.
The global Arthritis Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
Global Arthritis Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Arthritis Drug market, Segment by Type:
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Global Arthritis Drug market, by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Arthritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
The global Arthritis Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Arthritis Drug in various end use industries. The expanding demands from the Retail Pharmacies, Hospital Pharmacies, Drug Stores and E-Commerce, are propelling Arthritis Drug market. Synthetic DMARDs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological DMARDs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Arthritis Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Arthritis Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Arthritis Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Arthritis Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Arthritis Drug covered in this report include Novartis, Eli Lilly, Celltrion, F. Hoffmann-La Roche, Pfizer, Johnson & Johnson and GSK, etc.
The global Arthritis Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
Global Arthritis Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Arthritis Drug market, Segment by Type:
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Global Arthritis Drug market, by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Arthritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Arthritis Drug Market Overview
1.1 Arthritis Drug Product Overview
1.2 Arthritis Drug Market Segment by Type
1.2.1 Synthetic DMARDs
1.2.2 Biological DMARDs
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.2.5 Analgesics
1.3 Global Arthritis Drug Market Size by Type
1.3.1 Global Arthritis Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Arthritis Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Arthritis Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Arthritis Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Arthritis Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Arthritis Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Arthritis Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Arthritis Drug Sales Breakdown by Type (2018-2023)
2 Global Arthritis Drug Market Competition by Company
2.1 Global Top Players by Arthritis Drug Sales (2018-2023)
2.2 Global Top Players by Arthritis Drug Revenue (2018-2023)
2.3 Global Top Players by Arthritis Drug Price (2018-2023)
2.4 Global Top Manufacturers Arthritis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Arthritis Drug Market Competitive Situation and Trends
2.5.1 Arthritis Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Arthritis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Arthritis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Arthritis Drug Market
2.8 Key Manufacturers Arthritis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Arthritis Drug Status and Outlook by Region
3.1 Global Arthritis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Arthritis Drug Historic Market Size by Region
3.2.1 Global Arthritis Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Arthritis Drug Sales in Value by Region (2018-2023)
3.2.3 Global Arthritis Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Arthritis Drug Forecasted Market Size by Region
3.3.1 Global Arthritis Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Arthritis Drug Sales in Value by Region (2024-2029)
3.3.3 Global Arthritis Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Arthritis Drug by Application
4.1 Arthritis Drug Market Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Drug Stores
4.1.4 E-Commerce
4.2 Global Arthritis Drug Market Size by Application
4.2.1 Global Arthritis Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Arthritis Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Arthritis Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Arthritis Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Arthritis Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Arthritis Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Arthritis Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Arthritis Drug Sales Breakdown by Application (2018-2023)
5 North America Arthritis Drug by Country
5.1 North America Arthritis Drug Historic Market Size by Country
5.1.1 North America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Arthritis Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Arthritis Drug Sales in Value by Country (2018-2023)
5.2 North America Arthritis Drug Forecasted Market Size by Country
5.2.1 North America Arthritis Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Arthritis Drug Sales in Value by Country (2024-2029)
6 Europe Arthritis Drug by Country
6.1 Europe Arthritis Drug Historic Market Size by Country
6.1.1 Europe Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Arthritis Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Arthritis Drug Sales in Value by Country (2018-2023)
6.2 Europe Arthritis Drug Forecasted Market Size by Country
6.2.1 Europe Arthritis Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Arthritis Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Arthritis Drug by Region
7.1 Asia-Pacific Arthritis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Arthritis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Arthritis Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Arthritis Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Arthritis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Arthritis Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Arthritis Drug Sales in Value by Region (2024-2029)
8 Latin America Arthritis Drug by Country
8.1 Latin America Arthritis Drug Historic Market Size by Country
8.1.1 Latin America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Arthritis Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Arthritis Drug Sales in Value by Country (2018-2023)
8.2 Latin America Arthritis Drug Forecasted Market Size by Country
8.2.1 Latin America Arthritis Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Arthritis Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Arthritis Drug by Country
9.1 Middle East and Africa Arthritis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Arthritis Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Arthritis Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Arthritis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Arthritis Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Arthritis Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Arthritis Drug Products Offered
10.1.5 Novartis Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Arthritis Drug Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Celltrion
10.3.1 Celltrion Company Information
10.3.2 Celltrion Introduction and Business Overview
10.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Celltrion Arthritis Drug Products Offered
10.3.5 Celltrion Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 F. Hoffmann-La Roche Arthritis Drug Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Arthritis Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Arthritis Drug Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 GSK
10.7.1 GSK Company Information
10.7.2 GSK Introduction and Business Overview
10.7.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GSK Arthritis Drug Products Offered
10.7.5 GSK Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Arthritis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Arthritis Drug Industrial Chain Analysis
11.4 Arthritis Drug Market Dynamics
11.4.1 Arthritis Drug Industry Trends
11.4.2 Arthritis Drug Market Drivers
11.4.3 Arthritis Drug Market Challenges
11.4.4 Arthritis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Arthritis Drug Distributors
12.3 Arthritis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
